Changes in survival and time to progression in metastatic breast cancer (MBC) patients enrolled into clinical trials from 1983 to 2001.

被引：0
|
作者：
Gennari, A
Conte, P
Orlandini, C
Guarneri, V
Rosso, R
Bruzzi, P
机构：
[1] Div Med Oncol, Pisa, Italy
[2] Div Med Oncol, Modena, Italy
[3] NCI, Genoa, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
634
引用
收藏
页码：35S / 35S
页数：1
相关论文
共 50 条
  • [31] Long term survival in metastatic breast cancer (MBC): a retrospective analysis of 29 patients (pts)
    Senkus-Konefka, E
    Radecka, B
    Ilnicka, Z
    Symonowicz, H
    Kobierska, A
    Welnicka-Jaskiewicz, M
    Krasinska, L
    Jassem, J
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S74 - S75
  • [32] Time-to-progression in breast cancer:: A stratification model for clinical trials
    de la Haba-Rodriguez, Juan
    Aranda, Enrique
    Llombart, Antonio
    Lluch, Ana
    Alba, Emilio
    Munarriz, Blanca
    Adrover, Encarna
    Tusquets, Ignacio
    Balil, Ana
    Barnadas, Agusti
    Calvo, Lourdes
    Martin, Miguel
    BREAST, 2008, 17 (03): : 239 - 244
  • [33] Validation of time to treatment change (TTC) as a surrogate end-point of progression free survival (PFS) for observational trials in metastatic breast cancer patients (MBC): The GIM-13 AMBRA study.
    Cazzaniga, Marina Elena
    Pronzato, Paolo
    Meattini, Icro
    Biganzoli, Laura
    Taverniti, Cristiana
    Natoli, Clara
    De Placido, Sabino
    Aversa, Caterina
    Bordin, Elio
    Giordano, Monica
    Bologna, Alessandra
    Diodati, Lucrezia
    Blasi, Livio
    Garrone, Ornella
    Romagnoli, Emanuela
    Mocerino, Carmela
    D'Alonzo, Alessia
    Piezzo, Michela
    Mustacchi, Giorgio
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [34] Doubling time of progression-free survival by palbociclib in metastatic breast cancer
    L'Allemain, Gilles
    BULLETIN DU CANCER, 2015, 102 (04) : 300 - 300
  • [35] Association of age and overall survival in capecitabine-treated patients with metastatic breast cancer in clinical trials
    Joanne L. Blum
    Joseph Kohles
    Edward McKenna
    Nana Scotto
    Sylvia Hu
    Dawn Odom
    James A. Kaye
    Stefan Glück
    Breast Cancer Research and Treatment, 2011, 125 : 431 - 439
  • [36] Association of age and overall survival in capecitabine-treated patients with metastatic breast cancer in clinical trials
    Blum, Joanne L.
    Kohles, Joseph
    McKenna, Edward
    Scotto, Nana
    Hu, Sylvia
    Odom, Dawn
    Kaye, James A.
    Glueck, Stefan
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 125 (02) : 431 - 439
  • [37] Progression-free survival as a primary endpoint in clinical trials of metastatic colorectal cancer
    Gill, S.
    Berry, S.
    Biagi, J.
    Butts, C.
    Buyse, M.
    Chen, E.
    Jonker, D.
    Marginean, C.
    Samson, B.
    Stewart, J.
    Thirlwell, M.
    Wong, R.
    Maroun, J. A.
    CURRENT ONCOLOGY, 2011, 18 : S5 - S10
  • [38] Patterns of presentation, treatment and survival for older patients with metastatic breast cancer (MBC): results from a large prospective registry
    Hughes, Melissa
    Patterson, Alyssa
    Newman, Alexandra
    Higgins, Amanda
    Kirkner, Gregory
    Files, Janet
    Skeffington, Molly
    Moore, McKenna
    Strauss, Sarah
    Kuhnly, Nicole
    Crowley, Lindsey
    Tolaney, Sara
    Lin, Nancy
    Freedman, Rachel
    CANCER RESEARCH, 2024, 84 (09)
  • [39] Complementary Medicine Use Amongst Patients with Metastatic Cancer Enrolled in Phase III Clinical Trials
    Wells, J. Connor
    Sidhu, Aven
    Ding, Keyue
    Smoragiewicz, Martin
    Heng, Daniel Y. C.
    Shepherd, Frances A.
    Ellis, Peter M.
    Bradbury, Penelope A.
    Jonker, Derek J.
    Siu, Lillian L.
    Gelmon, Karen A.
    Karapetis, Christos
    Shapiro, Jeremy
    Nott, Louise
    O'Callaghan, Christopher J.
    Parulekar, Wendy R.
    Seymour, Lesley
    Monzon, Jose G.
    ONCOLOGIST, 2022, 27 (03): : E286 - E293
  • [40] COMPARISON OF SURVIVAL OUTCOMES OF RECURRENT GLIOBLASTOMA PATIENTS: A COMPARISON BETWEEN PATIENTS ENROLLED INTO CLINICAL TRIALS AND PATIENTS THAT DID NOT ENROLL INTO TRIALS AT FIRST PROGRESSION
    Balasubramanian, Geethanjali
    Yerramothu, Shruti
    Youssef, Gilbert
    Lee, Eudocia
    Castro, Luis Nicolas Gonzalez
    McFaline-Figueroa, Jose Ricardo
    Nayak, Lakshmi
    Reardon, David
    Trippa, Lorenzo
    Wen, Patrick
    Rahman, Rifaquat
    NEURO-ONCOLOGY, 2023, 25
12345